The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease.
December 16, 2020
Acist Medical Partners With Medis to Distribute Angiography Image Derived FFR Quantification System
December 16, 2020 – Acist Medical Systems Inc. announced a formal distribution partnership with Medis Medical Imaging…
Read More
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist
December 15, 2020
Cardiac Monitoring in the Time of COVID-19: Next Generation Wearable ECG Technology Comes into Its Own
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office…
Read More
Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) so the company to initiate a U.S. clinical study of its Tria biopolymer mitral surgical heart valve.
December 14, 2020
Foldax to Initiate FDA Clinical Study of Biopolymer Mitral Heart Valve
December 14, 2020 - Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an…
Read More
The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec, 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance.  #COVID #COVID19 #SARSCoV2 #vaccine #COVIDVaccine
Dave Fornell, Editor
December 14, 2020
FDA Clears First COVID-19 Vaccine Under an Emergency Use Authorization
December 14, 2020 — The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for…
Read More
SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The  TIVUS System for renal artery denervation treats resistant hypertension, which is defined as blood pressure that remains above 140/90 mmHg despite use of three antihypertensive medications of different classes at the best tolerated doses.
December 09, 2020
FDA Grants Breakthrough Device Designation for the TIVUS Renal Artery Denervation System
December 9, 2020 — SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to…
Read More
The Spectrum Dynamics Veriton-CT64 Digital SPECT/CT nuclear imaging system has its SPECT detectors housed in extendable arms to get as close to the patent's chest as possible to improve cardiac perfusion image quality. #RSNA2020 #RSNA20 #RSNA
December 04, 2020
Spectrum Dynamics Receives Approval From Health Canada for Veriton-CT64 Digital SPECT/CT
December 4, 2020 — Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for…
Read More
December 03, 2020
The DAIC November-December 2020 Digital Edition
View the November-December 2020 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine, include…
Read More
Attune Medical’s ensoETM is a single use thermal regulating device that is placed in the esophagus similar to a standard gastric tube and connected to an external heat exchange unit, creating a closed-loop system for heat transfer to increase or decrease patient temperature. Its placement in the esophagus, with proximity to blood flow from the heart and great vessels, allows highly efficient heat transfer. EPs are now looking at the device as a way to prevent RF damage to the esophagus during ablations.
December 03, 2020
Esophageal Cooling May Help Prevent Injury From Cardiac Ablations
December 3, 2020 – Attune Medical reports the first major peer-reviewed clinical publication using its ensoETM device…
Read More
An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients. #RSNA2020 #RSNA20 #RSNA
December 02, 2020
AI Measured Abdominal Fat Accurately Predicts Heart Attack and Stroke Risk
December 2, 2020 – Automated deep learning analysis of abdominal computed tomography (CT) images produces a more…
Read More
cyanosis, cyantosis COVID-positive infant.
December 02, 2020
COVID-19 Can Impact Hearts in Young Children
December 2, 2020 — A 2-month-old infant diagnosed with COVID-19 (SARS-CoV-2) experienced reversible myocardial injury…
Read More
CMS coverage changes effective as of Dec. 2, 2020 will open up the use of LVADs to more Medicare patients, including use of the HeartWare and HeartMate ventricular assist devices.
December 02, 2020
CMS Updates Coverage Policies for Artificial Hearts and Ventricular Assist Devices
December 2, 2020 — The Centers for Medicare and Medicaid Services (CMS) finalized updates to Medicare coverage policies…
Read More
GE Healthcare is introducing a new, smaller and lighter weight robotic driven angiography system for image guided therapy, the Allia IGS 7 angiography system. #RSNA20 #RSNA2020
December 01, 2020
GE Introduces Robotic Angiography Gantry That Addresses Ergonomic Issues
December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven angiography system for image guided…
Read More
Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging. #RSNA20 #RSNA2020
December 01, 2020
Arterys and Avicenna.AI Partner on AI Stroke Detection
December 1, 2020 – Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA…
Read More
COVID-19 cardiology related content continues to be among the top performers on the DAIC website in November 2020. TAVR also topped headlines with Boston Scientific taking its Lotus valve off the market and a review of TAVR registry data showing it is now the dominant method of aortic valve replacement in the United States. #DAIC
Dave Fornell, Editor
December 01, 2020
Most Popular Cardiology Technology Content in November 2020
December 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
A recent publication demonstrated procedural efficiency for MitraClip transcatheter mitral valve repair (TMVR) with use of the Baylis VersaCross RF Transseptal Solution, reporting guide delivery from femoral access in under 7.5 minutes.
December 01, 2020
Study Finds TMVR Procedural Efficiency Using the VersaCross RF Transseptal Solution
December 1, 2020 — A recent publication demonstrated procedural efficiency for MitraClip transcatheter mitral valve…
Read More
The Clarius PA HD hand-held, wireless ultrasound scanner is now available for high resolution cardiac imaging with the release of the Clarius Ultrasound App 7.3 for iOS and Android smart devices.
November 30, 2020
High-Definition Handheld Ultrasound Scanner Now Enables Rapid Bedside Cardiac Exams
November 30, 2020 — The Clarius PA HD hand-held, wireless ultrasound scanner is now available for high resolution…
Read More
The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.
November 24, 2020
FDA Clears First AI-Powered Algorithm Suite for Personal ECG Monitoring
November 24, 2020 — The U.S. Food and Drug Administration (FDA) has cleared AliveCor's next generation of interpretive…
Read More
One-year results off the PIONEER III study comparing the safety and efficacy of the Supreme HT drug-eluting stent (DES), to the Xience or Promus Durable Polymer DES showed it was equivalent in clinical performance to the market-leading DES. The results were presented at the 2020 American Heart Association (AHA) Scientific Session. #AHA2020 #AHA20 #AHA
November 24, 2020
Biodegradable Drug Eluting Coronary Stent Noninferior to Xience or Promus Durable Polymer Stents
November 24, 2020 — One-year results off the PIONEER III study comparing the safety and efficacy of the Supreme HT (…
Read More
The American Heart Association, AHA, late-breaking sessions, trials, studies. #AHA #AHA20 #AHA2020
Dave Fornell, Editor
November 20, 2020
American Heart Association 2020 Late-breaking Trial Presentations 
Here is a list of the American Heart Association (AHA) late-breaking clinical trial presentations at the 2020 Virtual…
Read More
Results from study of more than 14,000 patients across the United States show the heavy impact of cardiac disease on hospitalized COVID patients. COVID-19 patients with cardiovascular diseases have in-hospital mortality rates of between 25 to 38 percent. #AHA #AHA20 #AHA2020 #COVID19 #Coronavirus #SARSCoV2
Dave Fornell, Editor
November 18, 2020
COVID-19 Patients With Cardiovascular Disease Have In-hospital Mortality Rates of 25 to 38 Percent
November 18, 2020 — A late-breaking study at the 2020 American Heart Association (AHA) Scientific Sessions showed…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now